177 Lu-FAP-2286 Combined Chemotherapy in a Case of Thymus Nonkeratinizing Squamous Carcinoma With Superior Vena Cava Syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 41678786.
- Also identified by DOI 10.1097/RLU.0000000000006350 and PMC identifier 13132035.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We reported a 52-year-old man with thymus nonkeratinized squamous carcinoma presenting with acute superior vena cava syndrome (SVCS) who received 177 Lu-FAP-2286 treatment and followed by low-dose chemotherapy. 68 Ga-FAP-2286 PET/CT revealed significantly less intensity of the mediastinal mass comparing to pretherapy scan, as well as significant relief of SVCS. No adverse effects were observed.
Medical subject headings
- Superior Vena Cava Syndrome
- Carcinoma, Squamous Cell
- Lutetium
- Benzamides
- Thymus Neoplasms
- Oligopeptides